Annual Accounts Payable
$11.86 M
+$1.80 M+17.91%
December 31, 2023
Summary
- As of February 9, 2025, CERE annual accounts payable is $11.86 million, with the most recent change of +$1.80 million (+17.91%) on December 31, 2023.
- During the last 3 years, CERE annual accounts payable has risen by +$6.87 million (+137.59%).
Performance
CERE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$10.84 M
-$1.02 M-8.63%
March 31, 2024
Summary
- As of February 9, 2025, CERE quarterly accounts payable is $10.84 million, with the most recent change of -$1.02 million (-8.63%) on March 31, 2024.
- Over the past year, CERE quarterly accounts payable has dropped by -$702.00 thousand (-6.08%).
Performance
CERE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CERE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | -6.1% |
| 3 y3 years | +137.6% | +32.5% |
| 5 y5 years | +462.5% | +32.5% |
CERE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -15.2% | -27.6% | -32.5% |
| 5 y | 5-year | at high | -82.2% | -27.6% | -98.6% |
| alltime | all time | at high | -82.2% | -27.6% | -98.6% |
Cerevel Therapeutics Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $10.84 M(-8.6%) |
| Dec 2023 | $11.86 M(+17.9%) | $11.86 M(+2.8%) |
| Sep 2023 | - | $11.54 M(+22.9%) |
| Jun 2023 | - | $9.39 M(+28.4%) |
| Mar 2023 | - | $7.32 M(-27.3%) |
| Dec 2022 | $10.06 M | $10.06 M(-32.8%) |
| Sep 2022 | - | $14.97 M(+36.0%) |
| Jun 2022 | - | $11.01 M(+34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $8.18 M(-27.6%) |
| Dec 2021 | $11.30 M(+126.3%) | $11.30 M(+107.5%) |
| Sep 2021 | - | $5.45 M(+9.2%) |
| Jun 2021 | - | $4.99 M(-35.7%) |
| Mar 2021 | - | $7.75 M(+55.3%) |
| Dec 2020 | $4.99 M(+136.7%) | $4.99 M(+3189.2%) |
| Sep 2020 | - | $151.80 K |
| Dec 2019 | $2.11 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual accounts payable?
- What is the all time high annual accounts payable for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual accounts payable year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly accounts payable year-on-year change?
What is Cerevel Therapeutics Holdings annual accounts payable?
The current annual accounts payable of CERE is $11.86 M
What is the all time high annual accounts payable for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual accounts payable is $11.86 M
What is Cerevel Therapeutics Holdings annual accounts payable year-on-year change?
Over the past year, CERE annual accounts payable has changed by +$1.80 M (+17.91%)
What is Cerevel Therapeutics Holdings quarterly accounts payable?
The current quarterly accounts payable of CERE is $10.84 M
What is the all time high quarterly accounts payable for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly accounts payable is $14.97 M
What is Cerevel Therapeutics Holdings quarterly accounts payable year-on-year change?
Over the past year, CERE quarterly accounts payable has changed by -$702.00 K (-6.08%)